Mesenchymal tumor features predict response to immune-checkpoint blockade in glioblastoma

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Ghannam, J. Y. et al. Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma. Nat. Cancer https://doi.org/10.1038/s43018-026-01179-2 (2026).

Comments (0)

No login
gif